2019
DOI: 10.3341/kjo.2018.0059
|View full text |Cite
|
Sign up to set email alerts
|

Palpebral Conjunctival and Tarsal Stromal Tumor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 3 publications
0
3
0
Order By: Relevance
“…Including our cases, to date a total of 22 clinicopathologically well-characterized cases of COST have been reported (Table 1). [1][2][3][4][5][6] The lesions have occurred sporadically in patients of different age groups ranging from 11 to 66 years old (mean age = 45 years; median age = 46 years), mixed ethnicity (possibly more common in Chinese/Asian population), and a male-to-female ratio of 1.2:1. The majority of patients presented with a slowgrowing solid mass or cyst-like lesion, often asymptomatic or with slight conjunctival irritation/foreign body sensation; however, one case demonstrated rapid growth and was large enough to cause exotropia.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Including our cases, to date a total of 22 clinicopathologically well-characterized cases of COST have been reported (Table 1). [1][2][3][4][5][6] The lesions have occurred sporadically in patients of different age groups ranging from 11 to 66 years old (mean age = 45 years; median age = 46 years), mixed ethnicity (possibly more common in Chinese/Asian population), and a male-to-female ratio of 1.2:1. The majority of patients presented with a slowgrowing solid mass or cyst-like lesion, often asymptomatic or with slight conjunctival irritation/foreign body sensation; however, one case demonstrated rapid growth and was large enough to cause exotropia.…”
Section: Discussionmentioning
confidence: 99%
“…1,2 COST appears to be an extremely rare tumor, and to date, only 20 cases have been published in the literature showing a limited range of clinical manifestations with unifying histopathological and immunohistochemical findings, distinguishing this entity from its mimics. [1][2][3][4][5][6] In this report, we describe 2 additional cases of COST and review the previously published cases in an attempt to encapsulate the clinical and demographic characteristics and to expand the immunomorphological property of this emerging entity.…”
Section: Introductionmentioning
confidence: 99%
“…These patients are either already informed of their serological status (serology positive for HIV) or after the biological assessment. It is accepted that the prevalence of certain so-called opportunistic cancers is proportional to the number of cases of patients infected with HIV [1,[15][16][17]. This situation is particularly acute in countries like Congo-Brazzaville where the vast majority of patients do not have access to antiretroviral treatment.…”
Section: Discussionmentioning
confidence: 99%